Management of opioid use disorder in the USA: present status and future directions
Authors:
Top Cited Papers
- 1 April 2019
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 393 (10182) , 1760-1772
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with MorphineThe Journal of Pharmacology and Experimental Therapeutics, 2013
- Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid DependenceArchives of General Psychiatry, 2011
- Meta‐analysis of drug‐related deaths soon after release from prisonAddiction, 2010
- A Single-Question Screening Test for Drug Use in Primary CareArchives of internal medicine (1960), 2010
- Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives savedDrug and Alcohol Dependence, 2009
- Association of Substance Use Disorders With Childhood Trauma but not African Genetic Heritage in an African American CohortAmerican Journal of Psychiatry, 2009
- Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991–1992 and 2001–2002Drug and Alcohol Dependence, 2007
- A multi‐center randomized trial of buprenorphine–naloxone versus clonidine for opioid, detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkAddiction, 2005
- An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and researchJournal of Substance Abuse Treatment, 2005
- French Field Experience with BuprenorphineThe American Journal on Addictions, 2004